AMP-activated protein kinase (AMPK) sits at the crossroads of cellular energy sensing and metabolic regulation. Activated by exercise, fasting, and metabolic stress, AMPK triggers a cascade of adaptations that improve glucose handling, increase fat oxidation, and promote mitochondrial biogenesis. Several research peptides converge on this pathway, making it a central mechanism in metabolic peptide research.
AMPK: The Master Metabolic Sensor
AMPK functions as a fuel gauge for the cell. When cellular energy drops (high AMP:ATP ratio), AMPK activates and switches the cell into an energy-conserving state: anabolic processes (protein synthesis, lipogenesis) are inhibited while catabolic processes (glucose uptake, fatty acid oxidation, autophagy) are stimulated. This is the same metabolic switch that exercise and caloric restriction engage — which is why compounds that activate AMPK pharmacologically are termed "exercise mimetics."
MOTS-c: Mitochondrial AMPK Activator
MOTS-c is the first mitochondrial-derived peptide shown to activate AMPK and regulate nuclear gene expression. It inhibits folate cycle enzymes, increasing AICAR (an endogenous AMPK activator), which in turn activates AMPK. This retrograde mitochondria-to-nucleus signaling represents a novel pathway linking mitochondrial metabolic state to nuclear gene regulation. In obese mouse models, MOTS-c prevented weight gain and improved insulin sensitivity through this mechanism. Available at systemicpeptides.com.
5-Amino-1MQ: NNMT Inhibition and Metabolic Flux
5-Amino-1MQ approaches metabolic regulation from a different angle — inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme that consumes NAD+ precursors. By blocking NNMT, 5-Amino-1MQ increases cellular NAD+ availability, which supports SIRT1 activation and downstream AMPK signaling. This NAD+-SIRT1-AMPK axis is a major research target in metabolic and aging research.
SLU-PP-332: Exercise Mimicry via ERR
SLU-PP-332 is an agonist of estrogen-related receptors (ERRs), transcription factors that regulate mitochondrial biogenesis and oxidative metabolism genes. While not a direct AMPK activator, it engages overlapping downstream targets — mitochondrial gene programs and endurance-related adaptations — that converge with AMPK-mediated effects.
Implications for Metabolic Research
The convergence of multiple peptide compounds on AMPK-related pathways provides researchers with tools to dissect different nodes of the metabolic regulation network. MOTS-c activates AMPK through folate cycle inhibition, 5-Amino-1MQ through NAD+ salvage pathway modulation, and SLU-PP-332 through nuclear receptor activation. Each provides a distinct pharmacological entry point.
All metabolic research peptides are available at systemicpeptides.com.